Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

Clinical trial NCT01801852 · UNKNOWN

Trial details

NCT number: NCT01801852
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Glioma Hepatocellular Cancer Squamous Cell Lung Cancer Pancreatic Cancer Colon Cancer Prostate Cancer

Start date: 2013-01-01
Primary completion: 2016-05-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.